Select link below to view: http://www.friedlnews.com/article/epigenomics-ag-epigenomics-provides-additional-data-on-the-outcome-of-its-head-to-head-comparison
Select link below to view: https://www.friedlnews.com/article/epigenomics-ag-epigenomics-ag-reports-non-inferiority-of-blood-based-epi-procolon-reg-against-fecal
Curetis AG Initiates Clinical Trial in the U.S. Towards FDA Clearance December 6, 2012 – 10:44:28 – Prospective Multi-Center Trial to Enroll Over 2,000 Clinical Samples […]
As of October 1st 2012, the Office of Biorepositories and Biospecimen Research (OBBR) has moved to the Cancer Diagnosis Program of the Division of Cancer Treatment and Diagnosis of the National Cancer Institute, […]
Select link below to view original article: http://www.biotech-now.org/health/2012/07/fda-safety-and-innovation-act-a-monumental-step-forward-for-patients-with-rare-diseases?utm_source=newsletter&utm_medium=email&utm_campaign=0711